While the fact that DAS28-CRP performs better could be explained by the large interval of possible values of CRP and the relative speed with which it decreases after anti-inflammatory stimuli (bDMARDs, glucocorticoids), the fact remains that remission is a rare state in the treatment of RA, even in the age of bDMARDs. This evidence concerns the gene CRP and rheumatoid arthritis.